Research and Development Expense, Internal
ImmunityBio, Inc.·Business Segments·1 segment
Breakdown
Segments
Reportable SegmentView metric
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Reportable Segment | $42.72M | $46.68M | $43.91M | $55.97M | $47.91M |
| Total | $42.72M | $46.68M | $43.91M | $55.97M | $47.91M |